A randomized, double‐blind trial of pegfilgrastim versus filgrastim for the management of neutropenia during CHASE(R) chemotherapy for malignant lymphoma

Pegfilgrastim is a pegylated form of the granulocyte‐colony stimulating factor, filgrastim. Herein, we report the results of a multicentre, randomized, double‐blind phase III trial comparing the efficacy and safety of pegfilgrastim with filgrastim in patients with malignant lymphoma. Patients were r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Haematol
Hlavní autoři: Kubo, Kohmei, Miyazaki, Yasuhiko, Murayama, Tohru, Shimazaki, Ryutaro, Usui, Noriko, Urabe, Akio, Hotta, Tomomitsu, Tamura, Kazuo
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Haematological Malignancy
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5074273/
https://ncbi.nlm.nih.gov/pubmed/27072050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14088
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky